Daily Anesthesiology Research Analysis
Three impactful studies span innovation, clinical practice, and public health in anesthesiology and perioperative care. A lipid-based in situ gel of ropivacaine achieved multi-day analgesia without systemic toxicity in mice, a randomized trial found esketamine improved hemodynamic and respiratory stability during first-trimester surgical abortion versus sufentanil (with more PONV), and a large U.S. registry revealed striking racial and socioeconomic disparities in pediatric out-of-hospital cardi
Summary
Three impactful studies span innovation, clinical practice, and public health in anesthesiology and perioperative care. A lipid-based in situ gel of ropivacaine achieved multi-day analgesia without systemic toxicity in mice, a randomized trial found esketamine improved hemodynamic and respiratory stability during first-trimester surgical abortion versus sufentanil (with more PONV), and a large U.S. registry revealed striking racial and socioeconomic disparities in pediatric out-of-hospital cardiac arrest incidence and survival.
Research Themes
- Long-acting local anesthetic delivery for postoperative analgesia
- Sedation strategy optimizing hemodynamic and respiratory safety in ambulatory gynecologic procedures
- Health equity and outcomes in pediatric resuscitation
Selected Articles
1. An injectable in situ gel formed by ropivacaine with small lipid molecules to achieve long-term postoperative analgesia.
This preclinical study presents a stearic acid–ropivacaine hydrophobic ion-pair embedded in a glycerol monostearate in situ gel that provided multiday analgesia in mice while avoiding burst release. Histology and serum chemistry supported safety, suggesting a promising single-dose, long-acting local anesthetic platform for postoperative pain control.
Impact: A feasible, inexpensive, and scalable formulation enabling single-dose, week-long local anesthesia could reduce opioid use and resource burden in perioperative care.
Clinical Implications: If translated to humans, this platform could enable single-shot, long-acting field blocks or wound infiltration, reducing opioid requirements, catheter use, and frequent redosing. Rigorous human PK/safety and local tissue compatibility studies are needed before clinical use.
Key Findings
- A ropivacaine–stearic acid hydrophobic ion-pair (SA-ROP HIP) combined with glycerol monostearate formed an in situ gel (SA-ROP-GMS) that avoided burst release.
- In mouse pain models, a single injection provided multiday (nearly 10-day) analgesia.
- Histology and blood biochemistry indicated no systemic toxicity with SA-ROP-GMS.
- All excipients were small molecules with favorable manufacturability and cost.
Methodological Strengths
- Combined mechanistic formulation design (hydrophobic ion-pairing) with in vivo efficacy testing.
- Multimodal safety assessment (histopathology and serum biochemistry) in animal models.
Limitations
- Preclinical murine data; human pharmacokinetics, local tissue effects, and dose scaling remain unknown.
- Long-term local neurotoxicity and potential depot-related complications were not assessed.
Future Directions: Conduct GLP toxicology, large-animal nerve block studies, and first-in-human trials to define PK/PD, safety, and efficacy; compare with liposomal bupivacaine and catheter-based techniques.
Although local anesthetics (LA) are non-addictive and effective in managing postoperative pain, their short-term effects limit their clinical utility. In this study, we constructed an in situ gel injection formulation with stearic acid-ropivacaine hydrophobic ion-pair (HIP) and glycerol monoglyceride (SA-ROP-GMS) for multiday postoperative pain management. As an in situ gel, SA-ROP-GMS avoids the burst release effect common to water-soluble small molecule drugs in liposomes and hydrogels. Meanwhile, the hydrophobic i
2. Effect of Esketamine Compared with Sufentanil Combined with Propofol in Patients Undergoing First Trimester Surgical Abortion: A Randomized, Double-Blinded Clinical Trial.
In 197 patients undergoing first-trimester surgical abortion, esketamine with propofol yielded more stable SBP/DBP/MBP and HR than sufentanil, reduced apnea and hypoxemia, and maintained respiratory function; however, dizziness and PONV were more frequent. Findings support esketamine as a respiratory-sparing option for ambulatory gynecologic anesthesia with attention to antiemetic prophylaxis.
Impact: This randomized, double-blind trial directly informs drug selection for procedural anesthesia in a common ambulatory setting, balancing cardiorespiratory safety against PONV risk.
Clinical Implications: Consider esketamine over short-acting opioids for first-trimester abortion sedation to reduce apnea/hypoxemia and hemodynamic swings; integrate multimodal antiemetic prophylaxis and monitor for dizziness.
Key Findings
- Esketamine maintained more stable intraoperative SBP, DBP, MBP, and HR than sufentanil (all p≤0.014).
- Apnea and hypoxemia events were reduced with esketamine compared to sufentanil.
- Respiratory rate was similar, but PetCO2 parameters favored esketamine indicating better ventilatory stability.
- Dizziness and postoperative nausea and vomiting (PONV) were more frequent with esketamine.
Methodological Strengths
- Randomized, double-blinded design with adequate sample size (n=197).
- Clinically relevant primary outcomes capturing hemodynamic and respiratory stability.
Limitations
- Single-procedure context limits generalizability to other ambulatory surgeries.
- Increased PONV and dizziness may offset benefits without robust antiemetic protocols.
Future Directions: Compare esketamine-based regimens with multimodal antiemetic strategies, assess recovery profiles and patient satisfaction, and test across broader ambulatory surgical indications.
BACKGROUND: We explored whether esketamine anesthesia during first-trimester surgical abortion can reduce intraoperative hemodynamic fluctuations and improve patients' respiratory function. METHODS: A total of 197 patients who underwent a first-trimester surgical abortion were included in the analysis. Patients were randomly assigned to either the esketamine anesthesia group (group E, n=98) or sufentanil anesthesia group (group S, n=99). The primary outcomes were systolic blood pressure (SBP), diastolic blood pr
3. Sociodemographic disparities in incidence and survival for pediatric out-of-hospital cardiac arrest in the United States.
Using CARES registry data (2015–2019), Black children experienced over 4-fold higher OHCA incidence than White or Hispanic/Latino children, and those from highest-risk neighborhoods had more than twice the incidence than lowest-risk neighborhoods. Black children and those from highest-risk neighborhoods had significantly lower odds of survival to discharge and neurologically favorable survival.
Impact: Quantifies profound equity gaps in pediatric cardiac arrest, guiding resource allocation, prevention strategies, and targeted resuscitation quality improvement.
Clinical Implications: Anesthesia and critical care systems should prioritize community CPR training, dispatcher-assisted CPR, and prehospital access in high-risk neighborhoods; hospitals serving these communities may need enhanced pediatric resuscitation readiness and post-arrest care pathways.
Key Findings
- OHCA incidence per 100,000 was 15.5 in Black children vs 3.8 in White and 3.3 in Hispanic/Latino children (p<0.001).
- Children in the highest-risk neighborhoods had OHCA incidence of 11.6 vs 4.3 in lowest-risk neighborhoods (p<0.001).
- Black children had lower odds of survival to discharge (aOR 0.73, 95% CI 0.59–0.91) and neurologically favorable survival (aOR 0.64, 95% CI 0.50–0.82).
- Highest-risk neighborhoods were associated with lower survival to discharge (aOR 0.64) and neurologically favorable survival (aOR 0.54) compared with lowest-risk neighborhoods.
Methodological Strengths
- Large, multi-year registry analysis with adjusted models for survival outcomes.
- Clear incidence denominators and SES index construction enabling neighborhood-level insights.
Limitations
- Observational design limits causal inference; unmeasured confounding may persist.
- Registry coverage and coding variations could introduce misclassification bias.
Future Directions: Interventional studies targeting high-risk neighborhoods (CPR training, AED access, dispatcher protocols) and hospital-based equity initiatives to improve pediatric OHCA outcomes.
BACKGROUND: Sociodemographic disparities in pediatric out-of-hospital cardiac arrest (OHCA) outcomes exist; differences in pediatric OHCA incidence remain unknown. This study investigated the association between race, ethnicity, and socioeconomic status (SES) with pediatric OHCA incidence and survival. We hypothesized that children who are Black, Hispanic/Latino, or of lower SES would have higher incidence and lower survival rates compared to children who are White or of higher SES. METHODS: This is a retrospective c